Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

A novel oxidative-inflammatory biomarker for Parkinson's disease: clinical utility of the uric acid-to-albumin ratio.

Xiu W, Zhang G, Chen Y, Sun C, Gao Y, Li A, Zhang H, Shuai P, Cheng J, Wang J, Xiao X, Deng B.

Neurol Sci · 2026-10-07

DOI: 10.1007/s10072-026-09415-4PMID: 42839150

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Neuropsychiatric and Cognitive Symptom Evolution over the First Decade of Biomarker-Positive, Sporadic Parkinson's Disease.

Schoen I, Wang J, Xie SX, Caspell-Garcia C, Mamikonyan E, Stark M, Dahodwala N, Siderowf AD, Dobkin R, York MK, Weintraub D.

Mov Disord · 2026-10-06

DOI: 10.1002/mds.70557PMID: 42839627

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Amyloid, p-tau, neurofilament light, and α-synuclein cerebrospinal fluid biomarkers across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease.

Rizzo M, Teunissen CE, Zetterberg H, Blennow K, Kollmorgen G, Krüger R, Fernandes SBG, Aarsland D, Borejko O, Hu M, Chokoshvili D, Vijverberg JEGB, Lemstra AW, Tijms BM, Petzold GC, Brockmann K, Gasser T, Frisoni GB, Hort J, Nedelska Z, Hopøy AC, Fladby T, Jessen F, Düzel E, Spottke A, Höglinger GU, Mutel S, Chevalier C, Krishnan R, Visser PJ, Vos SJB, EPND consortium.

Alzheimers Dement (Amst) · 2026-10-06

DOI: 10.1002/dad2.70498PMID: 42841041

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Plasma PINK1/Parkin ratio and ATF5 as potential biomarkers associated with dyskinesia in Parkinson's disease.

Qian S, Xiang W, Chen K, Du Y, Xu B, Duan Q, Xiong X, Hou J, Jiang T, Xie D, Qian J, Xie C, Li J.

Neurobiol Dis · 2026-10-05

DOI: 10.1016/j.nbd.2026.107638PMID: 42833593

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Precision cognitive neurorehabilitation: dose, adaptivity, digital therapeutics and implementation.

Sander FW, Sallard É, Silva M, Schneider L, Diserens K, Graf C, Serino A, Sokolov AA.

Expert Rev Neurother · 2026-10-04

DOI: 10.1080/14737175.2026.2723909PMID: 42829810

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Clinical and biomarker predictors of α-synuclein seeding in cognitive impairment and motor parkinsonism.

Ye BS, VandeVrede L, Jeon S, Lee S, Choi M, Jeon S, Shin NY, Charters B, Plastini M, Kang S, Rim JH, Lim JB.

Parkinsonism Relat Disord · 2026-10-04

DOI: 10.1016/j.parkreldis.2026.108956PMID: 42854385

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Digital mobility assessment using wearable devices in people with Parkinson's disease: a feasibility and implementation study in Ghana (TraPCAf) compared with a UK cohort.

Bicer M, Kirk C, Agoriwo M, Cham M, Akpalu A, Okubadejo N, Sarvestan J, Lumsdon J, Okkaoglu Y, Brittain K, McArdle R, Alcock L, Yarnall AJ, Fothergill-Misbah N, Walker R, Rochester L, Del Din S, TraPCAf.

Front Aging Neurosci · 2026-10-02

DOI: 10.3389/fnagi.2026.1899045PMID: 42890933

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Study of blood linear RNA nominates CD55 and DLD as early-stage biomarkers for Parkinson's disease.

Beric A, Sahin S, Sanchez S, Yang Z, Kumar R, Alfradique-Dunham I, Sanford J, Western D, Phillips B, Budde JP, Perrin RJ, Kotzbauer PT, Perlmutter JS, Norris SA, Cruchaga C, Ibanez L.

Brain · 2026-10-01

DOI: 10.1093/brain/awag014PMID: 41525793

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The Fabulous Game of Parkinson Disease Biomarkers.

Fabiani G, Amarante DF.

Neurology · 2026-10-01

DOI: 10.1212/wnl.0000000000218639PMID: 42821846

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Circulating phosphatidylserine as a plasma biomarker for clinical staging and prognostic prediction in Parkinson's disease: A diagnostic validation study.

Shen H, Sun P, Ge B, Xiao J, Han X.

Clin Biochem · 2026-10-01

DOI: 10.1016/j.clinbiochem.2026.111213PMID: 42822624

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The A53T Parkinson's Disease Mouse Model Shows Abnormal Outer Retinal OCT Metabolic Biomarker Patterns.

Ataman ES, Nguyen CTO, Finkelstein DI, Wong VHY, Hoang A, Lee PY, Soetedjo J, Klopp B, Landowski M, Podolsky RH, Roberts R, Berkowitz BA.

Invest Ophthalmol Vis Sci · 2026-10-01

DOI: 10.1167/iovs.67.12.28PMID: 42878580

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

An Interpretable Framework for Identifying EEG Spectral Biomarkers of Pathological Brain Aging.

Prieur-Coloma Y, Prado P, El-Deredy W, Weinstein A.

Diagnostics (Basel) · 2026-09-27

DOI: 10.3390/diagnostics16193143PMID: 42882298

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

2.742 makale bulundu

A novel oxidative-inflammatory biomarker for Parkinson's disease: clinical utility of the uric acid-to-albumin ratio.

Neuropsychiatric and Cognitive Symptom Evolution over the First Decade of Biomarker-Positive, Sporadic Parkinson's Disease.

Amyloid, p-tau, neurofilament light, and α-synuclein cerebrospinal fluid biomarkers across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease.

Plasma PINK1/Parkin ratio and ATF5 as potential biomarkers associated with dyskinesia in Parkinson's disease.

Precision cognitive neurorehabilitation: dose, adaptivity, digital therapeutics and implementation.

Clinical and biomarker predictors of α-synuclein seeding in cognitive impairment and motor parkinsonism.

Digital mobility assessment using wearable devices in people with Parkinson's disease: a feasibility and implementation study in Ghana (TraPCAf) compared with a UK cohort.

Study of blood linear RNA nominates CD55 and DLD as early-stage biomarkers for Parkinson's disease.

The Fabulous Game of Parkinson Disease Biomarkers.

Circulating phosphatidylserine as a plasma biomarker for clinical staging and prognostic prediction in Parkinson's disease: A diagnostic validation study.

The A53T Parkinson's Disease Mouse Model Shows Abnormal Outer Retinal OCT Metabolic Biomarker Patterns.

An Interpretable Framework for Identifying EEG Spectral Biomarkers of Pathological Brain Aging.

Filtreler